Cayuga Medical Center

Ithaca, New York 14850

4 studies enrolling now · 10 studies all time

What they study most

Advanced Cancer, Advanced Solid Tumor, Advanced/Metastatic Solid Tumors, Breast Cancer, Cancer, Cancer Metastatic, Chronic Lymphocytic Leukemia (CLL), Colorectal Cancer, Diffuse Large B Cell Lymphoma (DLBCL), Esophageal Cancer, Follicular Lymphoma (FL), Gastric Cancer

Studies at this site

• A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors — Recruiting now
• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies — Recruiting now
• A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors — Recruiting now
• Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors — Recruiting now
• TEMPUS ARIES: A Biobank Registry Platform Study in Oncology — Recruiting now
• GEMINI-NSCLC: NSCLC Biomarker Study — Recruiting now
• Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery — Running, not enrolling
• Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer. — Stopped early
• Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) — Running, not enrolling